AAVT42 efficiently transduced neurons, improving cognitive functions in AD mouse models. Long-term BDNF expression alleviated cognitive impairments without affecting amyloid or tau pathology. Gene expression profiling indicated upregulation of synaptic genes, supporting neuroprotective effects. This evidence concerns the gene MAPT and Cognitive impairment.